PAREA welcomes the development of a European Biotech Act and strongly supports its goals. However, the initiative should explicitly address one of the clearest examples of market and regulatory failure in European health innovation: mental health. Mental health conditions represent one of the largest and most persistent unmet needs in Europe.
Psychedelic Access and Research European Alliance (PAREA)
NGO · Estonia · EU Transparency Register 163022446092-77
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 784 non-governmental organisations on this site, they rank #441 by legislative files engaged — a count of participation, not a measure of influence.
- Register category
- Non-governmental organisations
- Registered as
- Psychedelic Access and Research European Alliance (PAREA)
- Head office
- Charneca de Caparica, Portugal
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Psychedelic in PolicySpeak: request access →
Work at Psychedelic Access and Research European Alliance (PAREA)? so we know who speaks for it.
Their record over time
Psychedelic Access and Research European Alliance (PAREA) filed 2 positions between 6 Jun 2025 and 25 May 2026, across 1 of the 326 legislative files tracked here, attaching a full position paper 2 times.
What they argued
PAREA welcomes the Commissions ambition to strengthen the European biotech ecosystem. The Biotech Act can play a crucial role in unlocking innovation in areas that combine high public health need with persistent underinvestment - notably mental health. Mental health is not just another disease area. It is a foundational layer that cuts across all aspects of human life and societal functioning.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from Psychedelic Access and Research European Alliance (PAREA)’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.